About: Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates in the United States. Its pipeline includes CR-001, which is in Phase 3 clinical trial, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company has a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. for the development and commercialization of oncology therapeutics. The company was formerly known as GlycoMimetics, Inc. The company was founded in 2024 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $13.57 (-2.65%)
CBIO NASDAQ Crescent Biopharma, Inc.
Crescent Biopharma, Inc. share price
CBIO price activity
Último preço
$ 13,570
Variação (24h)
-0,37 USD (-2,65%)
Volume
490.49K
Volume (média 4 sem.)
-
Abertura
$ 14,78
Variação do dia
$ 13,46 - $ 14,78
Fechamento anterior
$ 13,94
Último negócio
06 Oct, 8:00 pm GMT+0
Atrasado
06 Oct, 8:00 pm GMT+0
CBIO price performance
Atrasado
06 Oct, 8:00 pm GMT+0
quote.marketSignals